Lung Cancer in People's Republic of China

被引：220
作者：
Gao, Shugeng [1 ]
Li, Ning [2 ]
Wang, Shuhang [2 ]
Zhang, Fan [1 ]
Wei, Wenqiang [3 ]
Li, Ni [4 ]
Bi, Nan [5 ]
Wang, Zhijie [6 ]
He, Jie [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Panjiayuan Nanli 17, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Clin Canc, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Off Canc Prevent & Control, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Off Canc Screening, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Dept Radiol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 10期
关键词：
SERVICES;
D O I：
10.1016/j.jtho.2020.04.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1567 / 1576
页数：10
相关论文
共 28 条
  • [1] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    de Castro Carpeno, J.
    Wadsworth, C.
    Melillo, G.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) : 1919 - 1929
  • [2] [陈万青 Chen Wanqing], 2019, [中国肿瘤, Bulletin of Chinese Cancer], V28, P23
  • [3] Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment
    Chen, Wanqing
    Xia, Changfa
    Zheng, Rongshou
    Zhou, Maigeng
    Lin, Chunqing
    Zeng, Hongmei
    Zhang, Siwei
    Wang, Lyon
    Yang, Zhixun
    Sun, Kexin
    Li, He
    Brown, Matthew D.
    Islami, Farhad
    Bray, Freddie
    Jemal, Ahmedin
    He, Jie
    [J]. LANCET GLOBAL HEALTH, 2019, 7 (02): : E257 - E269
  • [4] Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
    Gao, Shugeng
    Li, Ning
    Gao, Shunyu
    Xue, Qi
    Ying, Jianming
    Wang, Shuhang
    Tao, Xiuli
    Zhao, Jun
    Mao, Yousheng
    Wang, Bing
    Shao, Kang
    Lei, Wendong
    Wang, Dali
    Lv, Fang
    Zhao, Liang
    Zhang, Fan
    Zhao, Ziran
    Su, Kai
    Tan, Fengwei
    Gao, Yibo
    Sun, Nan
    Wu, Dawei
    Yu, Yue
    Ling, Yun
    Wang, Zhijie
    Duan, Chunjian
    Tang, Wei
    Zhang, Lei
    He, Shun
    Wu, Ning
    Wang, Jie
    He, Jie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 816 - 826
  • [5] Gao Shugeng, 2015, Zhonghua Wai Ke Za Zhi, V53, P727
  • [6] [高忠嵩 Gao Zhongsong], 2017, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V44, P1034
  • [7] CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer
    Guo, Qing
    Gao, Bu-Lang
    Zhang, Xue-Jing
    Liu, Guo-Chao
    Xu, Feng
    Fan, Qiong-Ying
    Zhang, Shao-Jing
    Yang, Bo
    Wu, Xiao-Hua
    [J]. ONCOLOGY RESEARCH, 2015, 22 (5-6) : 247 - 258
  • [8] A Prospective Randomized Phase III Study of Precise PORT for Patients with pIIIA-N2 NSCLC After Complete Resection and Adjuvant Chemotherapy
    Hui, Z.
    Men, Y.
    Hu, C.
    Zhou, Z.
    Liang, J.
    Feng, Q.
    Nan, B.
    Wang, X.
    Chen, D.
    Xiao, Z.
    Lv, J.
    Deng, L.
    Zhang, T.
    Wang, W.
    Gao, S.
    He, J.
    Wang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S238 - S239
  • [9] Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review
    Li, Ning
    Huang, Hui-Yao
    Wu, Da-Wei
    Yang, Zhi-Min
    Wang, Jun
    Wang, Jian-Sheng
    Wang, Shu-Hang
    Fang, Hong
    Yu, Yue
    Bai, Ying
    Yan, Zhao
    Cao, Ye
    Jiang, Min
    Liu, Yan-Fei
    Li, Kun-Yan
    Xu, Bing-He
    Sun, Yan
    He, Jie
    [J]. LANCET ONCOLOGY, 2019, 20 (11) : E619 - E626
  • [10] 4DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm
    Li, Yi
    Ma, Jing-lu
    Chen, Xin
    Tang, Feng-wen
    Zhang, Xiao-zhi
    [J]. RADIATION ONCOLOGY, 2016, 11
123